These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4625764)

  • 1. Antigenic relationship between the C4 inactivating substance produced by KB cell cultures and the first component of human complement (C1).
    Füst G; Kósa S
    Med Microbiol Immunol; 1972; 157(3):244-50. PubMed ID: 4625764
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific inactivation of the fourth complement component. II. In vitro studies.
    Garces MC; Jensen JA; Iglesias E
    Infect Immun; 1971 Oct; 4(4):446-51. PubMed ID: 5154891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic relationship between the fourth component of human and guinea pig complement.
    Ohanian SH; Borsos T
    J Immunol; 1975 Jan; 114(1 Pt 1):161-4. PubMed ID: 46239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-complementary substances produced by KB cell cultures infected and not infected with virus.
    Kósa Z; Füst G
    Acta Microbiol Acad Sci Hung; 1970; 17(4):381-91. PubMed ID: 4327674
    [No Abstract]   [Full Text] [Related]  

  • 5. The enzymatic measurement of binding of first component of guinea pig complement with formalized sheep erythrocytes sensitized with rabbit antiserum.
    Mori Y; Kawai N; Koyama J
    J Biochem; 1973 May; 73(5):951-8. PubMed ID: 4737266
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance of sheep erythrocytes to immune lysis by treatment of the cells with a human erythrocyte extract: studies on the site of inhibition.
    Hoffmann EM; Cheng WC; Tomeu EJ; Renk CM
    J Immunol; 1974 Nov; 113(5):1501-9. PubMed ID: 4424275
    [No Abstract]   [Full Text] [Related]  

  • 7. A functional abnormality of the fifth component of complement (C5) from human serum of individuals with a familial opsonic defect.
    Nilsson UR; Miller ME; Wyman S
    J Immunol; 1974 Mar; 112(3):1164-76. PubMed ID: 4204560
    [No Abstract]   [Full Text] [Related]  

  • 8. [The third component of complement and complement receptors (author's transl)].
    Okuda T; Tachibana T
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(9):657-67. PubMed ID: 4215099
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 10. The structure and function of the third component of guinea pig complement. I. The effect of chemical reagents on immune hemolysis and immune adherence reactivity.
    Okuda T
    Immunochemistry; 1973 Jun; 10(6):373-9. PubMed ID: 4738908
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenic reactivities of synthetic polymers. (I) Hemagglutination of polymers to red blood cells of various species and hemagglutination inhibition of guinea pig antisera.
    Chiu SY; Ke HR
    Taiwan Yi Xue Hui Za Zhi; 1977 Sep; 76(9):678-84. PubMed ID: 271196
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody-induced lysis of nucleated cells in agar gel.
    Juji T; Kano K; Milgrom F
    Int Arch Allergy Appl Immunol; 1971; 41(5):739-53. PubMed ID: 5005897
    [No Abstract]   [Full Text] [Related]  

  • 13. Specific inactivation of the fourth complement component. I. In vivo studies.
    Jensen JA; Garces MC; Iglesias E
    Infect Immun; 1971 Jul; 4(1):12-9. PubMed ID: 4263696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticomplementary activity in unaggregated "purified" macroglobulin paraproteins.
    Glovsky MM; Fudenberg HH
    Immunochemistry; 1971 Feb; 8(2):129-40. PubMed ID: 4102100
    [No Abstract]   [Full Text] [Related]  

  • 15. Complement biosynthesis in vitro by rat hepatoma cell strains.
    Strunk RC; Tashjian AH; Colten HR
    J Immunol; 1975 Jan; 114(1 Pt 2):331-5. PubMed ID: 163857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence for immune cytolysis by antibody and the first eight components of complement in the absence of C9.
    Tamura N; Shimada A; Chang S
    Immunology; 1972 Jan; 22(1):131-40. PubMed ID: 5013908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement.
    Gaither TA; Alling DW; Frank MM
    J Immunol; 1974 Aug; 113(2):574-83. PubMed ID: 4210883
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunochemical quantitation of cell bound C4.
    Ohanian SH; Borsos T
    J Immunol; 1974 Mar; 112(3):979-86. PubMed ID: 4359786
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement: effects of C1 binding affinity on the efficiency of the C2 reaction.
    Linscott WD
    J Immunol; 1972 Dec; 109(6):1327-36. PubMed ID: 4673616
    [No Abstract]   [Full Text] [Related]  

  • 20. C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.
    Ruddy S; Austen KF
    J Immunol; 1971 Sep; 107(3):742-50. PubMed ID: 4999095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.